Global Cell-based Flu Vaccine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 112
Published Date: 23 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Cell-based Flu Vaccine market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Cell-based Flu Vaccine industry chain, the market status of Aldults (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), Children (Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cell-based Flu Vaccine.
Regionally, the report analyzes the Cell-based Flu Vaccine markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cell-based Flu Vaccine market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Cell-based Flu Vaccine market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cell-based Flu Vaccine industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (M Doses), revenue generated, and market share of different by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cell-based Flu Vaccine market.
Regional Analysis: The report involves examining the Cell-based Flu Vaccine market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cell-based Flu Vaccine market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Cell-based Flu Vaccine:
Company Analysis: Report covers individual Cell-based Flu Vaccine manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cell-based Flu Vaccine This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Aldults, Children).
Technology Analysis: Report covers specific technologies relevant to Cell-based Flu Vaccine. It assesses the current state, advancements, and potential future developments in Cell-based Flu Vaccine areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cell-based Flu Vaccine market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Cell-based Flu Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market segment by Application
Aldults
Children
Major players covered
GlaxoSmithKline
Sanofi
Pfizer
MedImmune, LLC
Intravacc
CSL Limited
E. Merck KG
Novartis
Danaher Corporation
SINOVAC
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cell-based Flu Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cell-based Flu Vaccine, with price, sales, revenue and global market share of Cell-based Flu Vaccine from 2019 to 2024.
Chapter 3, the Cell-based Flu Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cell-based Flu Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Cell-based Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cell-based Flu Vaccine.
Chapter 14 and 15, to describe Cell-based Flu Vaccine sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Cell-based Flu Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cell-based Flu Vaccine Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Trivalent Influenza Vaccine
1.3.3 Quadrivalent Influenza Vaccine
1.4 Market Analysis by Application
1.4.1 Overview: Global Cell-based Flu Vaccine Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Aldults
1.4.3 Children
1.5 Global Cell-based Flu Vaccine Market Size & Forecast
1.5.1 Global Cell-based Flu Vaccine Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Cell-based Flu Vaccine Sales Quantity (2019-2030)
1.5.3 Global Cell-based Flu Vaccine Average Price (2019-2030)
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Cell-based Flu Vaccine Product and Services
2.1.4 GlaxoSmithKline Cell-based Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 GlaxoSmithKline Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Cell-based Flu Vaccine Product and Services
2.2.4 Sanofi Cell-based Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Sanofi Recent Developments/Updates
2.3 Pfizer
2.3.1 Pfizer Details
2.3.2 Pfizer Major Business
2.3.3 Pfizer Cell-based Flu Vaccine Product and Services
2.3.4 Pfizer Cell-based Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Pfizer Recent Developments/Updates
2.4 MedImmune, LLC
2.4.1 MedImmune, LLC Details
2.4.2 MedImmune, LLC Major Business
2.4.3 MedImmune, LLC Cell-based Flu Vaccine Product and Services
2.4.4 MedImmune, LLC Cell-based Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 MedImmune, LLC Recent Developments/Updates
2.5 Intravacc
2.5.1 Intravacc Details
2.5.2 Intravacc Major Business
2.5.3 Intravacc Cell-based Flu Vaccine Product and Services
2.5.4 Intravacc Cell-based Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Intravacc Recent Developments/Updates
2.6 CSL Limited
2.6.1 CSL Limited Details
2.6.2 CSL Limited Major Business
2.6.3 CSL Limited Cell-based Flu Vaccine Product and Services
2.6.4 CSL Limited Cell-based Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 CSL Limited Recent Developments/Updates
2.7 E. Merck KG
2.7.1 E. Merck KG Details
2.7.2 E. Merck KG Major Business
2.7.3 E. Merck KG Cell-based Flu Vaccine Product and Services
2.7.4 E. Merck KG Cell-based Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 E. Merck KG Recent Developments/Updates
2.8 Novartis
2.8.1 Novartis Details
2.8.2 Novartis Major Business
2.8.3 Novartis Cell-based Flu Vaccine Product and Services
2.8.4 Novartis Cell-based Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Novartis Recent Developments/Updates
2.9 Danaher Corporation
2.9.1 Danaher Corporation Details
2.9.2 Danaher Corporation Major Business
2.9.3 Danaher Corporation Cell-based Flu Vaccine Product and Services
2.9.4 Danaher Corporation Cell-based Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Danaher Corporation Recent Developments/Updates
2.10 SINOVAC
2.10.1 SINOVAC Details
2.10.2 SINOVAC Major Business
2.10.3 SINOVAC Cell-based Flu Vaccine Product and Services
2.10.4 SINOVAC Cell-based Flu Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 SINOVAC Recent Developments/Updates
3.1 Global Cell-based Flu Vaccine Sales Quantity by Manufacturer (2019-2024)
3.2 Global Cell-based Flu Vaccine Revenue by Manufacturer (2019-2024)
3.3 Global Cell-based Flu Vaccine Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Cell-based Flu Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Cell-based Flu Vaccine Manufacturer Market Share in 2023
3.4.2 Top 6 Cell-based Flu Vaccine Manufacturer Market Share in 2023
3.5 Cell-based Flu Vaccine Market: Overall Company Footprint Analysis
3.5.1 Cell-based Flu Vaccine Market: Region Footprint
3.5.2 Cell-based Flu Vaccine Market: Company Product Type Footprint
3.5.3 Cell-based Flu Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Cell-based Flu Vaccine Market Size by Region
4.1.1 Global Cell-based Flu Vaccine Sales Quantity by Region (2019-2030)
4.1.2 Global Cell-based Flu Vaccine Consumption Value by Region (2019-2030)
4.1.3 Global Cell-based Flu Vaccine Average Price by Region (2019-2030)
4.2 North America Cell-based Flu Vaccine Consumption Value (2019-2030)
4.3 Europe Cell-based Flu Vaccine Consumption Value (2019-2030)
4.4 Asia-Pacific Cell-based Flu Vaccine Consumption Value (2019-2030)
4.5 South America Cell-based Flu Vaccine Consumption Value (2019-2030)
4.6 Middle East and Africa Cell-based Flu Vaccine Consumption Value (2019-2030)
5.1 Global Cell-based Flu Vaccine Sales Quantity by Type (2019-2030)
5.2 Global Cell-based Flu Vaccine Consumption Value by Type (2019-2030)
5.3 Global Cell-based Flu Vaccine Average Price by Type (2019-2030)
6.1 Global Cell-based Flu Vaccine Sales Quantity by Application (2019-2030)
6.2 Global Cell-based Flu Vaccine Consumption Value by Application (2019-2030)
6.3 Global Cell-based Flu Vaccine Average Price by Application (2019-2030)
7.1 North America Cell-based Flu Vaccine Sales Quantity by Type (2019-2030)
7.2 North America Cell-based Flu Vaccine Sales Quantity by Application (2019-2030)
7.3 North America Cell-based Flu Vaccine Market Size by Country
7.3.1 North America Cell-based Flu Vaccine Sales Quantity by Country (2019-2030)
7.3.2 North America Cell-based Flu Vaccine Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Cell-based Flu Vaccine Sales Quantity by Type (2019-2030)
8.2 Europe Cell-based Flu Vaccine Sales Quantity by Application (2019-2030)
8.3 Europe Cell-based Flu Vaccine Market Size by Country
8.3.1 Europe Cell-based Flu Vaccine Sales Quantity by Country (2019-2030)
8.3.2 Europe Cell-based Flu Vaccine Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Cell-based Flu Vaccine Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Cell-based Flu Vaccine Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Cell-based Flu Vaccine Market Size by Region
9.3.1 Asia-Pacific Cell-based Flu Vaccine Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Cell-based Flu Vaccine Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Cell-based Flu Vaccine Sales Quantity by Type (2019-2030)
10.2 South America Cell-based Flu Vaccine Sales Quantity by Application (2019-2030)
10.3 South America Cell-based Flu Vaccine Market Size by Country
10.3.1 South America Cell-based Flu Vaccine Sales Quantity by Country (2019-2030)
10.3.2 South America Cell-based Flu Vaccine Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Cell-based Flu Vaccine Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Cell-based Flu Vaccine Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Cell-based Flu Vaccine Market Size by Country
11.3.1 Middle East & Africa Cell-based Flu Vaccine Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Cell-based Flu Vaccine Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Cell-based Flu Vaccine Market Drivers
12.2 Cell-based Flu Vaccine Market Restraints
12.3 Cell-based Flu Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Cell-based Flu Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cell-based Flu Vaccine
13.3 Cell-based Flu Vaccine Production Process
13.4 Cell-based Flu Vaccine Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cell-based Flu Vaccine Typical Distributors
14.3 Cell-based Flu Vaccine Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Cell-based Flu Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Cell-based Flu Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Cell-based Flu Vaccine Product and Services
Table 6. GlaxoSmithKline Cell-based Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. GlaxoSmithKline Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Cell-based Flu Vaccine Product and Services
Table 11. Sanofi Cell-based Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Sanofi Recent Developments/Updates
Table 13. Pfizer Basic Information, Manufacturing Base and Competitors
Table 14. Pfizer Major Business
Table 15. Pfizer Cell-based Flu Vaccine Product and Services
Table 16. Pfizer Cell-based Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Pfizer Recent Developments/Updates
Table 18. MedImmune, LLC Basic Information, Manufacturing Base and Competitors
Table 19. MedImmune, LLC Major Business
Table 20. MedImmune, LLC Cell-based Flu Vaccine Product and Services
Table 21. MedImmune, LLC Cell-based Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. MedImmune, LLC Recent Developments/Updates
Table 23. Intravacc Basic Information, Manufacturing Base and Competitors
Table 24. Intravacc Major Business
Table 25. Intravacc Cell-based Flu Vaccine Product and Services
Table 26. Intravacc Cell-based Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Intravacc Recent Developments/Updates
Table 28. CSL Limited Basic Information, Manufacturing Base and Competitors
Table 29. CSL Limited Major Business
Table 30. CSL Limited Cell-based Flu Vaccine Product and Services
Table 31. CSL Limited Cell-based Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. CSL Limited Recent Developments/Updates
Table 33. E. Merck KG Basic Information, Manufacturing Base and Competitors
Table 34. E. Merck KG Major Business
Table 35. E. Merck KG Cell-based Flu Vaccine Product and Services
Table 36. E. Merck KG Cell-based Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. E. Merck KG Recent Developments/Updates
Table 38. Novartis Basic Information, Manufacturing Base and Competitors
Table 39. Novartis Major Business
Table 40. Novartis Cell-based Flu Vaccine Product and Services
Table 41. Novartis Cell-based Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. Novartis Recent Developments/Updates
Table 43. Danaher Corporation Basic Information, Manufacturing Base and Competitors
Table 44. Danaher Corporation Major Business
Table 45. Danaher Corporation Cell-based Flu Vaccine Product and Services
Table 46. Danaher Corporation Cell-based Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Danaher Corporation Recent Developments/Updates
Table 48. SINOVAC Basic Information, Manufacturing Base and Competitors
Table 49. SINOVAC Major Business
Table 50. SINOVAC Cell-based Flu Vaccine Product and Services
Table 51. SINOVAC Cell-based Flu Vaccine Sales Quantity (M Doses), Average Price (US$/Dose), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. SINOVAC Recent Developments/Updates
Table 53. Global Cell-based Flu Vaccine Sales Quantity by Manufacturer (2019-2024) & (M Doses)
Table 54. Global Cell-based Flu Vaccine Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Cell-based Flu Vaccine Average Price by Manufacturer (2019-2024) & (US$/Dose)
Table 56. Market Position of Manufacturers in Cell-based Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 57. Head Office and Cell-based Flu Vaccine Production Site of Key Manufacturer
Table 58. Cell-based Flu Vaccine Market: Company Product Type Footprint
Table 59. Cell-based Flu Vaccine Market: Company Product Application Footprint
Table 60. Cell-based Flu Vaccine New Market Entrants and Barriers to Market Entry
Table 61. Cell-based Flu Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Cell-based Flu Vaccine Sales Quantity by Region (2019-2024) & (M Doses)
Table 63. Global Cell-based Flu Vaccine Sales Quantity by Region (2025-2030) & (M Doses)
Table 64. Global Cell-based Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 65. Global Cell-based Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 66. Global Cell-based Flu Vaccine Average Price by Region (2019-2024) & (US$/Dose)
Table 67. Global Cell-based Flu Vaccine Average Price by Region (2025-2030) & (US$/Dose)
Table 68. Global Cell-based Flu Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
Table 69. Global Cell-based Flu Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
Table 70. Global Cell-based Flu Vaccine Consumption Value by Type (2019-2024) & (USD Million)
Table 71. Global Cell-based Flu Vaccine Consumption Value by Type (2025-2030) & (USD Million)
Table 72. Global Cell-based Flu Vaccine Average Price by Type (2019-2024) & (US$/Dose)
Table 73. Global Cell-based Flu Vaccine Average Price by Type (2025-2030) & (US$/Dose)
Table 74. Global Cell-based Flu Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
Table 75. Global Cell-based Flu Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
Table 76. Global Cell-based Flu Vaccine Consumption Value by Application (2019-2024) & (USD Million)
Table 77. Global Cell-based Flu Vaccine Consumption Value by Application (2025-2030) & (USD Million)
Table 78. Global Cell-based Flu Vaccine Average Price by Application (2019-2024) & (US$/Dose)
Table 79. Global Cell-based Flu Vaccine Average Price by Application (2025-2030) & (US$/Dose)
Table 80. North America Cell-based Flu Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
Table 81. North America Cell-based Flu Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
Table 82. North America Cell-based Flu Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
Table 83. North America Cell-based Flu Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
Table 84. North America Cell-based Flu Vaccine Sales Quantity by Country (2019-2024) & (M Doses)
Table 85. North America Cell-based Flu Vaccine Sales Quantity by Country (2025-2030) & (M Doses)
Table 86. North America Cell-based Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 87. North America Cell-based Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 88. Europe Cell-based Flu Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
Table 89. Europe Cell-based Flu Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
Table 90. Europe Cell-based Flu Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
Table 91. Europe Cell-based Flu Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
Table 92. Europe Cell-based Flu Vaccine Sales Quantity by Country (2019-2024) & (M Doses)
Table 93. Europe Cell-based Flu Vaccine Sales Quantity by Country (2025-2030) & (M Doses)
Table 94. Europe Cell-based Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 95. Europe Cell-based Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 96. Asia-Pacific Cell-based Flu Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
Table 97. Asia-Pacific Cell-based Flu Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
Table 98. Asia-Pacific Cell-based Flu Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
Table 99. Asia-Pacific Cell-based Flu Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
Table 100. Asia-Pacific Cell-based Flu Vaccine Sales Quantity by Region (2019-2024) & (M Doses)
Table 101. Asia-Pacific Cell-based Flu Vaccine Sales Quantity by Region (2025-2030) & (M Doses)
Table 102. Asia-Pacific Cell-based Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 103. Asia-Pacific Cell-based Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 104. South America Cell-based Flu Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
Table 105. South America Cell-based Flu Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
Table 106. South America Cell-based Flu Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
Table 107. South America Cell-based Flu Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
Table 108. South America Cell-based Flu Vaccine Sales Quantity by Country (2019-2024) & (M Doses)
Table 109. South America Cell-based Flu Vaccine Sales Quantity by Country (2025-2030) & (M Doses)
Table 110. South America Cell-based Flu Vaccine Consumption Value by Country (2019-2024) & (USD Million)
Table 111. South America Cell-based Flu Vaccine Consumption Value by Country (2025-2030) & (USD Million)
Table 112. Middle East & Africa Cell-based Flu Vaccine Sales Quantity by Type (2019-2024) & (M Doses)
Table 113. Middle East & Africa Cell-based Flu Vaccine Sales Quantity by Type (2025-2030) & (M Doses)
Table 114. Middle East & Africa Cell-based Flu Vaccine Sales Quantity by Application (2019-2024) & (M Doses)
Table 115. Middle East & Africa Cell-based Flu Vaccine Sales Quantity by Application (2025-2030) & (M Doses)
Table 116. Middle East & Africa Cell-based Flu Vaccine Sales Quantity by Region (2019-2024) & (M Doses)
Table 117. Middle East & Africa Cell-based Flu Vaccine Sales Quantity by Region (2025-2030) & (M Doses)
Table 118. Middle East & Africa Cell-based Flu Vaccine Consumption Value by Region (2019-2024) & (USD Million)
Table 119. Middle East & Africa Cell-based Flu Vaccine Consumption Value by Region (2025-2030) & (USD Million)
Table 120. Cell-based Flu Vaccine Raw Material
Table 121. Key Manufacturers of Cell-based Flu Vaccine Raw Materials
Table 122. Cell-based Flu Vaccine Typical Distributors
Table 123. Cell-based Flu Vaccine Typical Customers
List of Figures
Figure 1. Cell-based Flu Vaccine Picture
Figure 2. Global Cell-based Flu Vaccine Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Cell-based Flu Vaccine Consumption Value Market Share by Type in 2023
Figure 4. Trivalent Influenza Vaccine Examples
Figure 5. Quadrivalent Influenza Vaccine Examples
Figure 6. Global Cell-based Flu Vaccine Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Cell-based Flu Vaccine Consumption Value Market Share by Application in 2023
Figure 8. Aldults Examples
Figure 9. Children Examples
Figure 10. Global Cell-based Flu Vaccine Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 11. Global Cell-based Flu Vaccine Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 12. Global Cell-based Flu Vaccine Sales Quantity (2019-2030) & (M Doses)
Figure 13. Global Cell-based Flu Vaccine Average Price (2019-2030) & (US$/Dose)
Figure 14. Global Cell-based Flu Vaccine Sales Quantity Market Share by Manufacturer in 2023
Figure 15. Global Cell-based Flu Vaccine Consumption Value Market Share by Manufacturer in 2023
Figure 16. Producer Shipments of Cell-based Flu Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 17. Top 3 Cell-based Flu Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 18. Top 6 Cell-based Flu Vaccine Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Global Cell-based Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 20. Global Cell-based Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 21. North America Cell-based Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 22. Europe Cell-based Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 23. Asia-Pacific Cell-based Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 24. South America Cell-based Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 25. Middle East & Africa Cell-based Flu Vaccine Consumption Value (2019-2030) & (USD Million)
Figure 26. Global Cell-based Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 27. Global Cell-based Flu Vaccine Consumption Value Market Share by Type (2019-2030)
Figure 28. Global Cell-based Flu Vaccine Average Price by Type (2019-2030) & (US$/Dose)
Figure 29. Global Cell-based Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 30. Global Cell-based Flu Vaccine Consumption Value Market Share by Application (2019-2030)
Figure 31. Global Cell-based Flu Vaccine Average Price by Application (2019-2030) & (US$/Dose)
Figure 32. North America Cell-based Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 33. North America Cell-based Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 34. North America Cell-based Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 35. North America Cell-based Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 36. United States Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 37. Canada Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Mexico Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Europe Cell-based Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 40. Europe Cell-based Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 41. Europe Cell-based Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 42. Europe Cell-based Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 43. Germany Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. France Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. United Kingdom Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. Russia Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Italy Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Asia-Pacific Cell-based Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 49. Asia-Pacific Cell-based Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 50. Asia-Pacific Cell-based Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 51. Asia-Pacific Cell-based Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 52. China Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Japan Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Korea Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. India Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. Southeast Asia Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Australia Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. South America Cell-based Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 59. South America Cell-based Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 60. South America Cell-based Flu Vaccine Sales Quantity Market Share by Country (2019-2030)
Figure 61. South America Cell-based Flu Vaccine Consumption Value Market Share by Country (2019-2030)
Figure 62. Brazil Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. Argentina Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Middle East & Africa Cell-based Flu Vaccine Sales Quantity Market Share by Type (2019-2030)
Figure 65. Middle East & Africa Cell-based Flu Vaccine Sales Quantity Market Share by Application (2019-2030)
Figure 66. Middle East & Africa Cell-based Flu Vaccine Sales Quantity Market Share by Region (2019-2030)
Figure 67. Middle East & Africa Cell-based Flu Vaccine Consumption Value Market Share by Region (2019-2030)
Figure 68. Turkey Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Egypt Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Saudi Arabia Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. South Africa Cell-based Flu Vaccine Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. Cell-based Flu Vaccine Market Drivers
Figure 73. Cell-based Flu Vaccine Market Restraints
Figure 74. Cell-based Flu Vaccine Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Cell-based Flu Vaccine in 2023
Figure 77. Manufacturing Process Analysis of Cell-based Flu Vaccine
Figure 78. Cell-based Flu Vaccine Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
GlaxoSmithKline Sanofi Pfizer MedImmune, LLC Intravacc CSL Limited E. Merck KG Novartis Danaher Corporation SINOVAC
Related Reports
05 Feb 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
